Mobile Health Intervention to Increase HIV Testing and Linkage to Care
2 other identifiers
interventional
1,800
1 country
3
Brief Summary
This 5-year project will test an mobile health approach to improve HIV self-testing (HST) and linkage to HIV-related care among high-risk men in China. HIV-negative men who have sex with men (MSM) will be randomly assigned to an intervention group: access to WeTest-WeLink (a mobile application-based HIV testing health promotion and risk reduction program), or a control group. Participant HST and sexual risk behaviors will be evaluated at baseline and at 6, 12, and 18 months post-baseline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Dec 2021
Typical duration for not_applicable hiv
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2021
CompletedFirst Submitted
Initial submission to the registry
July 27, 2022
CompletedFirst Posted
Study publicly available on registry
August 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2024
CompletedResults Posted
Study results publicly available
November 5, 2025
CompletedNovember 5, 2025
October 1, 2025
2.8 years
July 27, 2022
October 14, 2025
October 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Completing HIV Self-Testing
HIV self-testing is assessed by electronic confirmation of HIV self-test result submitted via a mobile app.
Months 6, 12, and 18
Secondary Outcomes (3)
Number of Participants With HIV Laboratory Test Results
Months 6, 12, and 18
Number of Participants Attending Initial HIV Care Appointment
Months 6, 12, and 18
Number of Participants Receiving Receipt of HIV Confirmatory Test
Months 6, 12, and 18
Other Outcomes (3)
Number of Participants Using HIV Prevention Services
Months 6, 12, and 18
Number of Participants Reporting Substance Use
Months 6, 12, and 18
Number of Participants Reporting Condomless Anal Sex
Months 6, 12, and 18
Study Arms (2)
WeTest-WeLink intervention
EXPERIMENTALParticipants will have access to "WeTest-WeLink" application on the WeChat platform, which provides multi-media contents on HIV-related health information, online self-assessments, linkage to providers, data reports, and personal stories, in addition to two-way communication with non-governmental organizations (NGOs), and free, additional HST.
Control
ACTIVE COMPARATORParticipants will receive contact information to local NGO to request basic information or receive emergency referrals; have access to "standard" WeChat group; and have free, additional HST.
Interventions
"WeTest-WeLink" application on the WeChat platform provides videos on HIV self-testing and linkage to care; informational articles on HIV, sexually transmitted infections (STI), testing, antiviral treatment (ART), and care; online behavioral self-assessments; linkage to providers; local data reports; stories about coping, wellness, and social support; two-way communication with NGO; and free, additional HST.
Contact information of local NGO for emergency referrals; free additional HST.
Eligibility Criteria
You may qualify if:
- years or older
- Chinese
- Cis-gender male
- Condomless anal sex with another man in the past 6 months
- Resident in the study location for at least 6 months and no desire to relocate during the study period
- In possession of a mobile "smart" phone with capability to download and use WeChat
- HIV-negative (verified through HIV self-test at enrollment)
- Able to give informed consent
You may not qualify if:
- HIV positive at enrollment
- Self-report coercion to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- Anhui Medical Universitycollaborator
- Rutgers Universitycollaborator
- University of Arkansascollaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (3)
Wuhan Centers for Disease Control and Prevention
Wuhan, Hubei, China
Suzhou Centers for Disease Control and Prevention
Suzhou, Jiangsu, China
Chengdu Tongle Health Counselling Service Center
Chengdu, Sichuan, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Don Operario
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Don Operario, PhD
Emory University
- PRINCIPAL INVESTIGATOR
Cui Yang, PhD
Rutgers University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 27, 2022
First Posted
August 2, 2022
Study Start
December 15, 2021
Primary Completion
October 10, 2024
Study Completion
October 10, 2024
Last Updated
November 5, 2025
Results First Posted
November 5, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data will be available for sharing after data analysis for this study is complete.
- Access Criteria
- Data will be made available for sharing with researchers, community-based organizations, and advisory committees for the purposes of secondary descriptive or exploratory analysis. Researchers interested in using this data can contact the study PI, Dr. Operario, at don.operario@emory.edu with a brief explanation of the planned analysis.
De-identified datasets and a comprehensive data dictionary will be made available for sharing with other researchers.